Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Radiation Chemotherapy in Newly Diagnosed Ependymoma
NCT01096368Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- May 2010
- Primary completion
- Dec 2021
- Modality
- Monoclonal Antibodies, Lipid-based Nanoparticles, Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of vincristine sulfate liposome injection, Cisplatin micelle injection (HA132), etoposide, cyclophosphamide in ependymoma, sponsored by Children's Oncology Group. Started May 2010; status: completed.
02
Drugs
vincristine sulfate liposome injectionCisplatin micelle injection (HA132)etoposidecyclophosphamide
03
Conditions
ependymoma
Beyond the preview
Go deeper on NCT01096368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096368.